Group 1 - The company has decided to abolish the supervisory board and amend its articles of association, transferring the supervisory board's powers to the audit committee of the board of directors [1][2] - The proposal to abolish the supervisory board and revise the articles of association requires approval from the shareholders' meeting [2][3] - The company has completed its governance structure adjustment, with the audit committee now assuming the supervisory board's responsibilities, leading to the corresponding abolition of the supervisory meeting rules [2] Group 2 - The company intends to reappoint Zhonghui Certified Public Accountants (Special General Partnership) as its auditing firm for the fiscal year 2025, based on a satisfactory working relationship and adherence to independent auditing standards [2][3] - The proposal for the reappointment of the auditing firm also requires approval from the shareholders' meeting [3]
欧康医药: 第四届监事会第九次会议决议公告